There's never a dull week on Wall Street. Let's go over some of the news that will shape the week to come.
The market kicks off with Celsion (NASDAQ:CLSN) reporting its latest quarterly results on Monday morning. The oncology specialist is targeting cancer tumor-targeting treatments through focused heat energy in combination with heat-activated liposomal drug technology. Analysts see Celsion posting a deficit in line with what it did a year earlier, and that's natural for upstart biotechs.
Gramercy Capital (NYSE:GPT) reports on Tuesday. Investors are hoping the REIT will reinstate its dividend later this year. Gramercy owns or has stakes in 116 office and industrial buildings totaling nearly 5 million square feet.
Jabil Circuit (NYSE:JBL) checks in on Wednesday. The contract manufacturer for electronics has been meandering lately. Analysts see Jabil posting a slight uptick in revenue but a slight dip in profitability.
Vringo (UNKNOWN:VRNG.DL) will be an interesting name to watch on Thursday. This was an obscure app developer at the start of last year, but acquiring some old Lycos search patents has given the small company ammo to go after dot-com giants over the past year.
The quarterly financials will be welcome, but investors will be more interested on how things are going on the patent litigation front.
Friday is usually quiet on the earnings front, so let's turn our attention to BlackBerry (NYSE:BB). The smartphone pioneer's Z10 -- the first smartphone with the ballyhooed BlackBerry 10 mobile operating system -- will be available in the U.S. for the first time on Friday.
Skeptics think it's too late for BlackBerry, but the shares have been beaten down so badly over the years that even a whiff of success can send the shares moving higher.